Target intelligence / Profile preview

RNA, U1 small nuclear 57, pseudogene (RNU1-57P)

Target
RNU1-57P
Molecular classification
Other (Pseudogene; non-coding RNA family member)
01

Overview

RNA, U1 small nuclear 57, pseudogene (RNU1-57P) is listed in human genome annotations as a pseudogene—specifically, a member of the non-coding small nuclear RNA U1 family, but without coding function[5]. Unlike canonical U1 snRNAs (such as RNU1-1), which are essential for accurate pre-mRNA splicing and transcriptome integrity, RNU1-57P does not produce a functional RNA and is not involved in splicing or transcriptional regulation[1][5]. Pseudogenes like RNU1-57P are remnants of genomic evolution and do not serve as direct molecular or therapeutic targets[5]. The entry is correctly abbreviated as RNU1-57P, matching the HGNC nomenclature[5]. Any reference to U1 snRNA biological functions pertains to active, non-pseudogene family members (e.g., RNU1-1), not RNU1-57P[1][5]. It is not a receptor, enzyme, transporter, or any other pharmacologically actionable target. There is no evidence of this locus being implicated in disease or targeted by drugs. All major databases, including GeneCards and HGNC, consistently classify RNU1-57P as a pseudogene with no known function, clinical relevance, or drug interactions[5].

Other names
RNA, U1 Small Nuclear 57, PseudogeneRNU1-57P

Beyond the preview

Go deeper on RNA, U1 small nuclear 57, pseudogene (RNU1-57P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 57, pseudogene (RNU1-57P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call